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Abstract. Image segmentation enables to extract quantitative mea-
sures from scans that can serve as imaging biomarkers for diseases.
However, segmentation quality can vary substantially across scans, and
therefore yield unfaithful estimates in the follow-up statistical analysis
of biomarkers. The core problem is that segmentation and biomarker
analysis are performed independently. We propose to propagate segmen-
tation uncertainty to the statistical analysis to account for variations in
segmentation confidence. To this end, we evaluate four Bayesian neu-
ral networks to sample from the posterior distribution and estimate the
uncertainty. We then assign confidence measures to the biomarker and
propose statistical models for its integration in group analysis and dis-
ease classification. Our results for segmenting the liver in patients with
diabetes mellitus clearly demonstrate the improvement of integrating
biomarker uncertainty in the statistical inference.
1 Introduction
Imaging biomarkers play a crucial role in tracking disease progression, in sup-
porting an automated prediction of diagnosis, and in providing novel insights
in the pathophysiology of diseases [5, 23, 24]. A prerequisite for many image-
based markers is image segmentation, which provides access to morphological
features like volume, thickness and shape information [6, 7, 22]. Despite a boost
in segmentation accuracy by deep learning [15], automated segmentations are
not perfect and their quality can vary substantially across scans. As a conse-
quence, segmentation errors propagate to errors in the derived biomarker. To
reduce the impact of erroneous segmentations in follow-up analyses and to infer
faithful estimates, a manual quality control is advised to identify segmentations
of sufficient quality. However, the manual quality assessment is subject to intra-
and inter-rater variability and time consuming, particularly for large datasets.
Fortunately, Bayesian neural networks for image segmentation [10, 13, 14]
have been developed that do not only provide the mode (i.e., the most likely
segmentation) but also the posterior distribution of the segmentation. Monte
Carlo (MC) dropout [3, 10] or the probabilistic U-Net [13, 14] enable to sample
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multiple possible segmentations instead of only a single segmentation. Typically,
a voxel-wise uncertainty is then computed and displayed to the user to detect
regions with lower segmentation confidence In contrast, we want to use the seg-
mentation uncertainty to derive a biomarker uncertainty. With such a measure,
we could directly determine the scans from which biomarkers have been ex-
tracted reliably without the need for a manual quality control. However, the
integration of the segmentation uncertainty into follow-up analyses of extracted
biomarkers, such as group analyses or disease classification, has not yet been
well studied. In addition, it is not clear which Bayesian segmentation method
is best suited for inferring the uncertainty of the biomarker, capturing different
aspects of aleatoric and epistemic uncertainty.
To address these issues, we present statistical models that integrate segmen-
tation confidence measures in the parameter inference of the biomarker. Fur-
ther, we compare four state-of-the-art Bayesian neural networks for computing
the segmentation and confidence measures. We perform experiments for the seg-
mentation of the liver in abdominal magnetic resonance imaging (MRI) scans in
subjects with diabetes mellitus. Our results demonstrate that the integration of
biomarker uncertainty yields estimates that are closer to the manual reference
and higher classification accuracy.
Related Work Several approaches have been proposed to compute uncer-
tainty for the segmentation of medical images [1, 2, 8, 9, 16, 18, 21, 25]. We have
previously used MC dropout to compute the uncertainty in whole-brain segmen-
tation [17,18]. Nair et al. [16] provide four different voxel-based uncertainty mea-
sures based on MC dropout. The reliability of uncertainty estimations for image
segmentation has been evaluated in [9]. Eaton et al. [2] presented uncertainty for
calibrating confidence boundary for robust predictions of tumor segmentations.
Hu et al. [8] used calibrated inter-grader variability as a target for training a CNN
model to predict aleatoric uncertainty. Sedai et al. [21] used uncertainty guided
domain alignment to train a model for retinal and choroidal layers segmentation
in OCT images. In [25], Yu et al. incorporate uncertainty in a teacher CNN to
guide a student CNN in a semi-supervised segmentation setup. The architecture
for multi-scale ambiguity detection and uncertainty quantification proposed by
Baumgartner et al. [1] is similar to the hierarchical model in [14], which we also
use in this work. Uncertainty-driven bootstrapping for data selection and model
training was proposed in [4]. In contrast to prior work, we focus on propagating
segmentation to the statistical analysis of imaging biomarkers.
2 Methods
2.1 Bayesian Neural Networks for Image Segmentation
Essential for our approach of estimating the biomarker uncertainty are Bayesian
segmentation networks that enable to sample from the predictive posterior dis-
tribution. Several strategies to perform variational inference within fully convo-
lutional neural networks (F-CNNs) have been proposed in the literature, where
we describe four commonly used and promising approaches in the following.
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Fig. 1: Schematic illustration of the four Bayesian neural networks that we use
for segmentation.
Monte-Carlo Dropout Dropout layers were first adapted within deep neural
networks to perform variational inference by Gal et al. [3]. This was later adopted
for image segmentation in computer vision [10] and medical imaging [18]. The
main idea is to keep the dropout layers active during inference, see Fig. 1(i). This
enforces the neurons to be stochastic within the network and generates multiple
segmentation maps for a single image. These multiple Monte-Carlo segmentation
samples are aggregated to generate the final segmentation and its corresponding
uncertainty map.
Fully-Bayesian F-CNN with Re-Parameterization We replace the convo-
lutional layers in the segmentation network with a Bayesian convolution layer, see
Fig. 1(ii), which has been developed using the re-parameterization trick [11,12].
We are not aware of a previous application of this approach for segmentation.
The Bayesian layer consists of two convolution layers, whose outputs are further
processed to add non-linearity by adding a tanh activation at each layer. We
consider the outputs from the tanh layers as µθ and σθ. A Gaussian white noise
ε is multiplied with σθ to introduce stochasticity and the product is added to µθ
gθ(ε) = µθ + εσθ and ε ∼ N (0, 0.1). (1)
Kingma et al. [11, 12] used a Gaussian distribution with mean 0 and standard
deviation 1 in their experiments. We reduce the standard deviation to 0.1 to
restrict higher variation in σθ.
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Probabilistic U-Net Kohl et al. [13] proposed the probabilistic U-Net. They
suggested that ambiguous medical images can have multiple plausible segmenta-
tions based on multiple graders and that capturing this spectrum of variability
is more meaningful than estimating the uncertainty maps. In this regard, along
with the base segmentation network, they train a separate network termed prior
net, which maps the input to an embedding hypothesis space, see Fig. 1(iii). One
sample from this hypothesis space is concatenated to the last feature map of the
base segmentation network to generate one segmentation output. Thus, multiple
plausible segmentations are generated with sampling different points from the
learnt hypothesis embedding space.
Hierarchical Probabilistic U-Net Kohl et al. [14] further improved the prob-
abilistic U-Net [13] to incorporate multi-scale ambiguity. In case the target organ
exists in multiple scales, it is important to capture the spectrum of variation
across all the scales. The previous work from the authors successfully captured
only the variation across one scale. Thus, they modified the network to capture
the underlying variation across multiple scales. The main idea is to learn mul-
tiple hypothesis embedding spaces, each one specific to a specific target scale,
see Fig. 1(iv). In every encoder-decoder based F-CNN, it is assumed that differ-
ent scale-specific features are learnt at each stage of the decoder with different
spatial resolution. Therefore, during inference, multiple scale specific samples
generated from different hypothesis embedding spaces are concatenated to their
corresponding decoder feature map of appropriate scale. Consequently, different
sets of samples from different embeddings generate multiple plausible segmenta-
tion maps.
2.2 Confidence Measure
Bayesian neural networks commonly provide a measure of uncertainty per voxel.
As many biomarkers are associated to organs, we need an uncertainty measure
per organ. To this end, we will use the intersection over union (IoU) and the co-
efficient of variation (CV) [18]. For the IoU, we consider N segmentation samples
S1, . . . , SN from the network for the organ o
IoU =
|(S1 == o) ∩ (S2 == o) ∩ ...(SN == o)|
|(S1 == o) ∪ (S2 == o) ∪ ...(SN == o)| . (2)
In our application, we use N = 10 and o = liver.
In our analyses, we focus on the volume of the liver. Instead of quantify-
ing uncertainty with regards to segmentation, we can also directly measure the
variation of the volume across the segmentation samples. Considering volumes
V1, . . . , VN computed from the N segmentation maps and the mean volume µ,
the coefficient of variation is
CV =
√∑
(Vi − µ)2
N · µ2 . (3)
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Note that this estimate is agnostic to the size of the structure. As a high
coefficient of variation indicates an erroneous segmentation, we use the inverse,
CV−1, as confidence measure, while the IoU can be used directly.
2.3 Statistical Methods
We want to integrate the segmentation confidence measures in the biomarker
analysis to enable a more faithful and reliable estimation of model parameters.
We present statistical models for group analysis and disease classification in the
following.
Group Analysis In the group analysis, we evaluate the association of the
biomarker with respect to non-imaging variables. For our application of diabetes,
we consider the age Ai, sex Si, BMI Bi, and diabetes status Di for subject i.
The base model for the liver volume Vi is
Base Model: Vi = β0 + β1Ai + β2Si + β3Bi + β4Di + ε, (4)
where β0, . . . , β4 are regression coefficients and ε is the noise term.
We now want to integrate the confidence measure Ci that is associated to
the volume Vi and comes from the Bayesian segmentation into the model. As
first approach, we propose to add the confidence measure as additional variable
to the model
Variable: Vi = β0 + β1Ai + β2Si + β3Bi + β4Di + β5Ci + ε. (5)
As alternative, we use the confidence measure as instance weight in the re-
gression model. Instead of giving equal importance to each subject i, subjects
with higher confidence in the liver segmentation will be given higher importance
in the estimation of the coefficients
Instance Weighting: [Vi = β0 + β1Ai + β2Si + β3Bi + β4Di + ε] · Ci. (6)
Weighted least squares is used for estimating the model coefficients, where
the confidence measures are used as weights. Note that manual quality control
is a special case of instance weighting with a binary confidence measure, where
only those segmentations with passing quality are set to one and the rest to zero.
Disease Classification For the prediction of the diabetes status, we use logistic
regression. In the base model, we use the liver volume as input feature. For the
integration of the confidence measure in the classification model, we consider
three variants. First, we add the confidence measure Ci as additional variable to
the model. Second, we do not only consider the additive effect of the confidence
measure but also the interaction, so that Vi · Ci is also added to the model.
Third, we use instance weighting based on the confidence measure to emphasize
subjects with good segmentations.
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Fig. 2: (a) Bars show mean Dice score of liver and error bars show standard devi-
ation for different segmentation networks. (b) Bars show the mean liver volume
of diabetic and non-diabetic subjects for manual and automated segmentation,
error bars indicate standard deviation.
3 Results
3.1 Data
Experiments are performed on a set of whole-body Magnetic Resonance Images
(MRI) obtained from the Cooperative Health Research in the Region Augsburg
project (KORA). We work with 308 subjects (109 diabetic, 199 non-diabetic)
that have a manual annotation of the liver. We resample all volumes to a stan-
dard resolution of 2× 2× 3 mm3 and 53× 256× 144 voxels.
3.2 Bayesian segmentation results
We use QuickNAT [19, 20] as base architecture for implementing Bayesian net-
works in Fig. 1. We use common network parameters across models with learning
rate 1e-5, batch size 5, and 50 epochs. For MC Dropout, we use a dropout rate
of 0.2. For Fully-Bayesian, we do not use a batch normalization layer. Instead,
we use uni-variate KL-Divergence loss to regularize the distribution of weights
from each Bayesian layer. For the probabilistic and hierarchical models, a latent
variable of dimension 12 has been used to estimate the posterior embedding.
We split the dataset into 155 training (56 diabetic, 99 non-diabetic) and 153
testing (53 diabetic, 100 non-diabetic) subjects by equally distributing diabetic
and non-diabetic subjects.
Fig. 2(a) shows a boxplot of the Dice score of the liver for different seg-
mentation methods. We observe that MC dropout yields the highest accuracy,
followed by hierarchical, probabilistic, and Fully-Bayesian. Overall, the perfor-
mance of the models is high, but the error bars indicate that accuracy substan-
tially varies across subjects. Fig. 3 visualizes the predictions and uncertainty
maps for the different segmentation methods. We observe that MC Dropout and
Fully-Bayesian give a higher uncertainty in comparison to the other two. The
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Fig. 3: Top: MRI scan overlaid by segmentation map (white) and manual anno-
tation (red contour). Bottom: Voxel-wise uncertainty map of the segmentation.
probabilistic and hierarchical models were designed to learn annotations from
multiple raters, while we only have annotations from a single rater, which may
explain the lower stochasticity of these models in our experiments.
3.3 Group analysis
Table 1 reports the regression coefficient of the diabetes status β4, which is of
primary interest for studying diabetes, where Fig. 2(b) illustrates that diabetic
subjects tend to have a higher liver volume. The table shows the coefficient for
different segmentation methods and statistical models. Next to the base model,
and the integration of the confidence measure as additional variable and instance
weight, we also estimate the coefficient from the manual segmentation, which
serves as reference. All regression coefficients are estimated on the segmentation
test set.
MC Dropout with IoU as additional variable or instance weight yields coeffi-
cients that are closest to the manual estimate. For the probabilistic and hierar-
chical models, adding IoU to the model leads to the best results. The coefficient
of the Fully-Bayesian network has the highest divergence from the manual es-
timate across segmentation methods, but inclusion of confidence measures as
variables helps to improve the estimate.
3.4 Disease classification
For the classification experiment, we split the segmentation test set further into a
classification training set (77 subjects, 27 diabetic, 50 non-diabetic) and a classi-
fication test set (76 subjects, 26 diabetic, 50 non-diabetic) randomly 1,000 times.
Table 2 reports the mean classification accuracy across all runs. We compare dif-
ferent methods for segmentation and integration of the confidence measures.
The accuracy for volumes derived from manual annotations is 0.713; the accu-
racy decreases for all automated segmentations in the base model. The inclusion
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Table 1: Regression coefficient of diabetes status, β4, for different segmentation
approaches and statistical models, together with the manual estimate.
Base
Variable Instance
IoU CV-1 IoU CV-1 Manual
MC Dropout 0.308 0.318 0.308 0.316 0.268
0.328
Fully-Bayesian 0.255 0.269 0.271 0.254 0.229
Probabilistic 0.287 0.302 0.297 0.287 0.192
Hierarchical 0.294 0.306 0.288 0.295 0.249
Table 2: Accuracy for diabetes classification with logistic regression for different
segmentation methods and manual segmentation. The base model is compared
to several approaches of including the confidence measure in the estimation.
Base
Variable Interaction Instance
Manual
IoU CV-1 IoU CV-1 IoU CV-1
MC Dropout 0.702 0.719 0.709 0.716 0.712 0.706 0.708
0.713
Fully-Bayesian 0.692 0.705 0.696 0.705 0.695 0.695 0.696
Probabilistic 0.691 0.719 0.696 0.732 0.694 0.691 0.696
Hierarchical 0.702 0.714 0.694 0.714 0.695 0.703 0.699
of the confidence measures in the classification helps to recover the accuracy
and even pass the one from the manual segmentation. The likely reason for this
behaviour is that the confidence measures vary between diagnostic groups and
therefore provide additional information for the classification. We observe the
best performance for the variable and interaction models with IoU. The overall
best result is obtained by the probabilistic model with IoU interaction term.
4 Conclusion
In this work, we proposed to propagate segmentation uncertainty to the bio-
marker analysis as the segmentation quality can vary substantially between
scans. Our results have demonstrated that assigning a confidence score to an
imaging biomarker can yield a more faithful estimation of model parameters
and a higher classification accuracy. We have evaluated four Bayesian neural
networks with the best results for MC dropout and the probabilistic model,
each one in combination with IoU as confidence measure. These results show a
clear improvement over a base model that does not consider segmentation un-
certainty, and therefore confirms the necessity of propagating uncertainty to the
final biomarker analysis.
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